Propanc Biopharma Undertaking PRP Manufacturing & Development for Human Use Novel Proenzyme Pharmaceutical Formulation to be Administered by Intravenous (I.V.) Injection in World First, Phase I ...
Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today ...
Novel Proenzyme Pharmaceutical Formulation to be Administered by Intravenous (I.V.) Injection in World First, Phase I First-In-Human Study in Advanced Cancer Patients Propanc Biopharma, Inc. (OTCQB: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results